Yüksel Ürün, Medical Oncology Professor at Ankara University School of Medicine, shared a post on X about a recent article he and his colleagues co-authored, adding:
“EV-P is changing first-line care for advanced urothelial carcinoma.
A global survey shows where we still hesitate: neuropathy ≥G2, ECOG-PS ≥3, non-UC >50%.”
Title: Guiding First-Line Treatment Decisions In Advanced Urothelial Carcinoma: A Global Survey
Authors: Enrique Grande, Joaquim Bellmunt, Syed A Hussain, Mubarak M Al Mansour, Aristotle Bamias, Philippe Barthélémy, David J Benjamin, Normand Blais, Maria T Bourlon, Daniel Castellano, Pongwut Danchaivijitr, Mauricio Fernandez Lazzaro, Patrizia Giannatempo, Félix Guerrero-Ramos, Roberto Iacovelli, Philipp Ivanyi, Eun Hee Jung, Ravindran Kanesvaran, Ray Manneh, Joana C Marinho, Nobuaki Matsubara, Axel S Merseburger, Deborah Mukherji, Chandler H Park, Ben Tran, Karine Martins da Trindade, Yüksel Ürün, Ashish M Kamat, Alison J Birtle
Read the Full Article on The Oncologist
More posts featuring Yüksel Ürün.